comprehensive -WSS

comprehensive

author：entertainment 2025-08-23 06:43:28 - browse：27277

Photo illustration of Chris Viehbacher -- biotech coverage from STAT — Chris Viehbacher took over as Biogen CEO in November. Suzanne Kreiter/Globe staff; Photo illustration Alex Hogan/STAT

This was supposed to be the new Biogen. When Chris Viehbacher, a respected pharmaceutical executive, took over as CEO in November, Wall Street saw him as a steadying force for the wayward company and a strong personality who would stand up to its quarrelsome board.

Instead, Biogen’s board has saddled Viehbacher with the first crisis of his tenure at the company. Alex Denner, a long-time director, nominated a biotech executive who is also the mother of his child to succeed him on the board, and Biogen chose not to disclose the couple’s relationship to shareholders, an omission that shocked people close to the company and undermined the notion that Biogen was changing for the better.

“It’s just disappointing to see after all the criticism that has been levied at the company over the last few years, there really seems to be no self-awareness going into this recommendation,” said Brian Skorney, a securities analyst at Baird who covers Biogen.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Harvard's Jason Buenrostro wins MacArthur grant for genetics work

WSS

STAT Summit: How researchers deal with rejection

France's anti

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

Roche drug slashes death risk in early

France's anti

Antibody drugs appear effective. Now can we make enough of them?

hotspot

comprehensive

hotspot

ChatGPT in medicine: STAT answers readers' burning questions

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

Alkermes shareholders re

Roche acquires Telavant from Roivant, adding experimental IBD treatment

ChatGPT in medicine: STAT answers readers' burning questions

Roche acquires Telavant from Roivant, adding experimental IBD treatment

FDA approval of Sarepta Duchenne genetic therapy gives me hope

STAT Readout: Friday, Oct. 20 biotech updates

Affirmative action in medical school literally saved lives

Watch the official trailer for 'Ahsoka' series

knowledge

STAT Summit: Ending the crisis of Black deaths in the U.S.

How AI can help patients find reliable information about doctors

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Health tech investors get more selective as pandemic boom fades

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Cassava Sciences’ Alzheimer’s clinical trials should be halted

focus

leisure time

focus

entertainment